EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $53,980 | -72.3% | 45,746 | +77.0% | 0.00% | -100.0% |
| Q3 2022 | $195,000 | +204.7% | 25,846 | +153.4% | 0.00% | – |
| Q2 2022 | $64,000 | -36.0% | 10,200 | -15.0% | 0.00% | – |
| Q1 2022 | $100,000 | -42.5% | 12,000 | -64.1% | 0.00% | – |
| Q4 2021 | $174,000 | -76.5% | 33,446 | -69.8% | 0.00% | -100.0% |
| Q3 2021 | $740,000 | -50.6% | 110,739 | -37.0% | 0.00% | -50.0% |
| Q2 2021 | $1,497,000 | -50.2% | 175,739 | -48.2% | 0.00% | -50.0% |
| Q1 2021 | $3,005,000 | -37.4% | 339,539 | -13.1% | 0.01% | -38.5% |
| Q4 2020 | $4,801,000 | +80.8% | 390,639 | +19.7% | 0.01% | +62.5% |
| Q3 2020 | $2,656,000 | +3.8% | 326,339 | +22.4% | 0.01% | 0.0% |
| Q2 2020 | $2,560,000 | +66.2% | 266,639 | +17.7% | 0.01% | +33.3% |
| Q1 2020 | $1,540,000 | +44.3% | 226,539 | +216.2% | 0.01% | +200.0% |
| Q4 2019 | $1,067,000 | +502.8% | 71,639 | +315.6% | 0.00% | – |
| Q3 2019 | $177,000 | -34.9% | 17,239 | -32.8% | 0.00% | -100.0% |
| Q2 2019 | $272,000 | +13.3% | 25,639 | +49.6% | 0.00% | 0.0% |
| Q1 2019 | $240,000 | – | 17,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |